Application

17047529 · PHARMACEUTICAL COMBINATION PRODUCTS COMPRISING A HISTONE DEACETYLASE (HDAC) INHIBITOR AND A TLR7 AGONIST AND/OR TLR8 AGONIST FOR THE TREATMENT OF CANCER

Filed 2020-10-14 · Abandoned The official file ↗ · Art unit 1622 · Examiner Pierre Paul Eleniste Hard · CPC A61K 31/4155 · 4SC AG · MILLEN, WHITE, ZELANO & BRANIGAN, P.C.

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

26.1 mo

to disposition 50.1 mo

Statutes raised

102 103 DP

3 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.